Champions Oncology, Inc.
CSBR
$7.05
-$0.02-0.28%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 267.00K | -436.00K | -1.84M | 4.50M | 728.00K |
| Total Depreciation and Amortization | 357.00K | 358.00K | 394.00K | 398.00K | 399.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 646.00K | 479.00K | 582.00K | 514.00K | 94.00K |
| Change in Net Operating Assets | -3.01M | 199.00K | 7.73M | -4.92M | -1.50M |
| Cash from Operations | -1.74M | 600.00K | 6.87M | 490.00K | -283.00K |
| Capital Expenditure | -242.00K | -46.00K | -253.00K | -42.00K | -94.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -242.00K | -46.00K | -253.00K | -42.00K | -94.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -39.00K | -38.00K | -38.00K | -38.00K | -37.00K |
| Issuance of Common Stock | 207.00K | 24.00K | 6.00K | 38.00K | 276.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 168.00K | -14.00K | -32.00K | 0.00 | 239.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.81M | 540.00K | 6.58M | 448.00K | -138.00K |